Bullish option flow detected in Horizon Pharma with 2,956 calls trading, 1.2x expected, and implied vol increasing almost 4 points to 19.92%. Feb-23 115 calls and Feb-23 109 puts are the most active options, with total volume in those strikes near 2,400 contracts. The Put/Call Ratio is 0.10. Earnings are expected on March 1st.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HZNP:
- Amgen price target lowered to $275 from $285 at Wells Fargo
- Amgen price target lowered to $258 from $268 at RBC Capital
- Amgen price target lowered to $253 from $276 at BMO Capital
- Amgen, Horizon Therapeutics receive second request for additional info from FTC
- Warren writes FTC over concerns of two pharma deals, Reuters reports
